SMARCA4 and neoplasm: Although alterations of the chromatin pathway were not associated with the stage, grade, progression, or molecular subtypes of either tumor type, we found that alterations of KMT2C, SMARCA4, or EP300 lead to rapid relapse and progression of NMIBC.